EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 191 filers reported holding EAGLE PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 0.76 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $318,000 | -30.3% | 6,635 | -33.1% | 0.02% | -39.3% |
| Q1 2020 | $456,000 | -28.1% | 9,920 | -6.0% | 0.03% | +12.0% |
| Q4 2019 | $634,000 | +17.6% | 10,550 | +10.8% | 0.02% | +4.2% |
| Q3 2019 | $539,000 | -42.1% | 9,525 | -43.0% | 0.02% | -33.3% |
| Q2 2019 | $931,000 | -35.3% | 16,725 | -12.1% | 0.04% | +2.9% |
| Q2 2018 | $1,440,000 | +14.1% | 19,030 | -20.6% | 0.04% | +25.0% |
| Q1 2018 | $1,262,000 | -9.1% | 23,955 | -7.9% | 0.03% | 0.0% |
| Q4 2017 | $1,389,000 | -11.0% | 26,005 | -0.7% | 0.03% | -12.5% |
| Q3 2017 | $1,561,000 | – | 26,180 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 94,922 | $4,063,000 | 1.33% |
| Smith, Graham & Co., Investment Advisors, LP | 277,572 | $11,880,000 | 1.05% |
| Krensavage Asset Management, LLC | 70,804 | $3,030,000 | 1.03% |
| BRANDES INVESTMENT PARTNERS, LP | 716,873 | $30,682,000 | 0.68% |
| GLOBEFLEX CAPITAL L P | 42,357 | $1,813,000 | 0.33% |
| Zebra Capital Management LLC | 6,472 | $277,000 | 0.32% |
| Capital Impact Advisors, LLC | 19,276 | $825,000 | 0.27% |
| Hein Park Capital Management LP | 31,977 | $1,369,000 | 0.26% |
| CHARTWELL INVESTMENT PARTNERS, LLC | 195,340 | $8,361,000 | 0.25% |
| Stanley-Laman Group, Ltd. | 24,000 | $1,027,000 | 0.15% |